| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |